Risk of Deaths, AIDS-Defining and Non-AIDS Defining Events among Ghanaians on Long-Term Combination Antiretroviral Therapy

被引:11
|
作者
Sarfo, Fred Stephen [1 ,2 ]
Sarfo, Maame Anima [1 ]
Norman, Betty [1 ]
Phillips, Richard [1 ,2 ]
Bedu-Addo, George [1 ,2 ]
Chadwick, David [3 ]
机构
[1] Komfo Anokye Teaching Hosp, Kumasi, Ghana
[2] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana
[3] James Cook Univ Hosp, Middlesbrough, Cleveland, England
来源
PLOS ONE | 2014年 / 9卷 / 10期
关键词
RECONSTITUTION INFLAMMATORY SYNDROME; HIV-INFECTED ADULTS; CD4 CELL COUNTS; IMMUNE RECONSTITUTION; HIV-1-INFECTED PATIENTS; RENAL DYSFUNCTION; TREATMENT PROGRAM; LOW-INCOME; DISEASE; INDIVIDUALS;
D O I
10.1371/journal.pone.0111400
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Combination antiretroviral therapy (cART) has been widely available in Ghana since 2004. The aim of this cohort study was to assess the incidences of death, AIDS-defining events and non-AIDS defining events and associated risk factors amongst patients initiating cART in a large treatment centre. Clinical and laboratory data were extracted from clinic and hospital case notes for patients initiating cART between 2004 and 2010 and clinical events graded according to recognised definitions for AIDS, non-AIDS events (NADE) and death, with additional events not included in such definitions such as malaria also included. The cumulative incidence of events was calculated using Kaplan Meier analysis, and association of risk factors with events by Cox proportional hazards regression. Data were closed for analysis on 31st December, 2011 after a median follow-up of 30 months (range, 0-90 months). Amongst 4,039 patients starting cART at a median CD4 count of 133 cells/mm(3), there were 324 (8%) confirmed deaths, with an event rate of 28.83 (95% CI 25.78-32.15) deaths per 1000-person follow-up years; the commonest established causes were pulmonary TB and gastroenteritis. There were 681 AIDS-defining events (60.60 [56.14-65.33] per 1000 person years) with pulmonary TB and chronic diarrhoea being the most frequent causes. Forty-one NADEs were recorded (3.64 [2.61-4.95] per 1000 person years), of which hepatic and cardiovascular events were most common. Other common events recorded outside these definitions included malaria (746 events) and respiratory tract infections (666 events). Overall 24% of patients were lost-to-follow-up. Alongside expected risk factors, stavudine use was associated with AIDS [adjusted HR of 1.08 (0.90-1.30)] and death (adjusted HR of 1.60 [1.21-2.11]). Whilst frequency of AIDS and deaths in this cohort were similar to those described in other sub-Saharan African cohorts, rates of NADEs were lower and far exceeded by events such as malaria and respiratory tract infections.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation
    Pettit, April C.
    Giganti, Mark J.
    Ingle, Suzanne M.
    May, Margaret T.
    Shepherd, Bryan E.
    Gill, Michael J.
    Fatkenheuer, Gerd
    Abgrall, Sophie
    Saag, Michael S.
    Del Amo, Julia
    Justice, Amy C.
    Miro, Jose M.
    Cavasinni, Matthias
    Dabis, Francois
    Monforte, Antonella D.
    Reiss, Peter
    Guest, Jodie
    Moore, David
    Shepherd, Leah
    Obel, Niels
    Crane, Heidi M.
    Smith, Colette
    Teira, Ramon
    Zangerle, Robert
    Sterne, Jonathan A. C.
    Sterling, Timothy R.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [2] Antiretroviral combination therapies and AIDS-defining cancers
    Serraino, D
    Pezzotti, P
    Boros, S
    Rezza, G
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 24 (01) : 84 - 86
  • [3] AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era
    Silverberg, Michael J.
    Abrams, Donald I.
    [J]. CURRENT OPINION IN ONCOLOGY, 2007, 19 (05) : 446 - 451
  • [4] Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy
    Galli, Laura
    Spagnuolo, Vincenzo
    Poli, Andrea
    Salpietro, Stefania
    Gianotti, Nicola
    Cossarini, Francesca
    Carbone, Alessia
    Nozza, Silvia
    Bossolasco, Simona
    Bigoloni, Alba
    Lazzarin, Adriano
    Castagna, Antonella
    [J]. AIDS, 2014, 28 (16) : 2407 - 2415
  • [5] Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy
    Marin, Benoit
    Thiebaut, Rodolphe
    Bucher, Heiner C.
    Rondeau, Virginie
    Costagliola, Dominique
    Dorrucci, Maria
    Hamouda, Osamah
    Prins, Maria
    Walker, Sarah
    Porter, Kholoud
    Sabin, Caroline
    Chene, Genevieve
    [J]. AIDS, 2009, 23 (13) : 1743 - 1752
  • [6] Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy
    Brodt, HR
    Kamps, BS
    Gute, P
    Knupp, B
    Staszewski, S
    Helm, EB
    [J]. AIDS, 1997, 11 (14) : 1731 - 1738
  • [7] Decreasing incidence of CNS AIDS-defining events associated with antiretroviral therapy
    Monforte, AD
    Duca, PG
    Vago, L
    Grassi, MP
    Moroni, M
    [J]. NEUROLOGY, 2000, 54 (09) : 1856 - 1859
  • [8] Effect of AIDS-defining events at initiation of antiretroviral therapy on long-term mortality of HIV/AIDS patients in Southwestern China: a retrospective cohort study
    Yunxuan Huang
    Oulu Zhou
    Zhigang Zheng
    Yuexiang Xu
    Yi Shao
    Chunwei Qin
    Fengxiang Qin
    Jingzhen Lai
    Huifang Liu
    Rongfeng Chen
    Li Ye
    Hao Liang
    Xionglin Qin
    Junjun Jiang
    [J]. AIDS Research and Therapy, 17
  • [9] Effect of AIDS-defining events at initiation of antiretroviral therapy on long-term mortality of HIV/AIDS patients in Southwestern China: a retrospective cohort study
    Huang, Yunxuan
    Zhou, Oulu
    Zheng, Zhigang
    Xu, Yuexiang
    Shao, Yi
    Qin, Chunwei
    Qin, Fengxiang
    Lai, Jingzhen
    Liu, Huifang
    Chen, Rongfeng
    Ye, Li
    Liang, Hao
    Qin, Xionglin
    Jiang, Junjun
    [J]. AIDS RESEARCH AND THERAPY, 2020, 17 (01)
  • [10] Variable Impact on Mortality of AIDS-Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS-Defining Conditions Are Created Equal Antiretroviral Therapy Cohort Collaboration (ART-CC)
    Mocroft, Amanda
    Sterne, Jonathan A. C.
    Egger, Matthias
    May, Margaret
    Grabar, Sophie
    Furrer, Hansjakob
    Sabin, Caroline
    Fatkenheuer, Gerd
    Justice, Amy
    Reiss, Peter
    Monforte, Antonella d'Arminio
    Gill, John
    Hogg, Robert
    Bonnet, Fabrice
    Kitahata, Mari
    Staszewski, Schlomo
    Casabona, Jordi
    Harris, Ross
    Saag, Michael
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 48 (08) : 1138 - 1151